Research member at the Institute, Marie-Claude Bourgeois-Daigneault, and her team at the CRCHUM have published a study in Nature Communications showing how they have succeeded in creating a personalized, effective and anti-cancer-specific vaccine.
The vaccine combines oncolytic viruses with small synthetic molecules (peptides) specific to the targeted cancer. It allows it to attack the cancer both by killing it directly and by inducing an immune response through the virus. The effectiveness of the immunization has been demonstrated in an animal model.
Spotlight on two of our member researchers
2 May 2023
Congratulations to Dominic Roy and Dr. Bertrand Routy, research members of the institute. In the Junior 1 category, Mr. Dominic […]
Thomas Gervais’ Discovery Named One of Québec Science’s Top 10 of 2021
18 January 2022
Research member Thomas Gervais, a full professor in the Department of Engineering Physics at Polytechnique Montreal, and his team have […]